Press "Enter" to skip to content

New patent for Melinta Therap drug KIMYRSA

0
Copyright © DrugPatentWatch. Originally published at New patent for Melinta Therap drug KIMYRSA

Annual Drug Patent Expirations for KIMYRSA
Annual Drug Patent Expirations for KIMYRSA

Kimyrsa is a drug marketed by Melinta Therap and is included in one NDA. It is available from one supplier.

The generic ingredient in KIMYRSA is oritavancin diphosphate. One supplier is listed for this compound. Additional details are available on the oritavancin diphosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Melinta Therap drug KIMYRSA
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions